Flora Growth Launches JustCBD on Amazon UK
Flora Growth Corp. (NASDAQ: FLGC) has announced that its subsidiary, JustCBD, will launch its CBD products on Amazon.co.uk following UK Novel Foods authorization. This move allows JustCBD to enter the £700 million UK CBD market, which has seen Amazon expand its program for compliant vendors since October 2021. CEO Hussein Rakine expressed excitement about enhancing product offerings and expanding internationally. The launch is expected in June 2022, focusing on popular gummies and tinctures, thus broadening Flora's consumer base.
- JustCBD granted UK Novel Foods authorization, permitting entry into Amazon.co.uk.
- Launch allows Flora to tap into the £700 million UK CBD market.
- Partnership with Amazon expected to facilitate international growth.
- JustCBD's product range includes best-selling gummies and tinctures.
- None.
- JustCBD’s best selling products will launch on Amazon.co.uk after JustCBD was awarded with
- Amazon
- Flora and JustCBD aim to continue working with Amazon to expand into other countries and markets over time
Amazon
“With health and wellness playing an increasingly important role in customers’ lives, we are excited to increase the selection of quality CBD products offered to Amazon customers in the UK,” said Hussein Rakine, CEO of JustCBD. “The JustCBD team looks forward to working closely with Amazon to expand our product offering to other countries as our partnership and brand presence in the
JustCBD’s product line is expected to launch on Amazon.co.uk in June of 2022 and will make available a portfolio of JustCBD’s best-selling gummies and tinctures.
“International growth is a key objective of our company’s strategy. The launch on Amazon
About
Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands delivering the most compelling customer experiences in the world, one community at a time. As the operator of one of the most extensive outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house of brands, and life sciences divisions. Visit www.floragrowth.com or follow @floragrowthcorp on social media for more information.
Cautionary Statement Concerning Forward-Looking Statements
This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; our environmental and sustainability practices and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking events discussed in this document and other statements made from time to time by us or our representatives not occurring, except as may be required by applicable law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220531005293/en/
Investor Relations:
ir@floragrowth.com
Public Relations:
+1 (858) 221-8001
flora@cmwmedia.com
Source:
FAQ
When will JustCBD products be available on Amazon.co.uk?
What are the benefits of UK Novel Foods authorization for JustCBD?
How does Flora Growth Corp. plan to expand its market presence?